| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2023 | -0.5% | BMO Capital | $13 → $7 | Maintains | Market Perform |
| 11/02/2023 | -28.93% | Barclays | $9 → $5 | Maintains | Underweight |
| 10/12/2023 | -28.93% | Mizuho | → $5 | Downgrades | Neutral → Underperform |
| 09/22/2023 | -57.36% | Piper Sandler | $6 → $3 | Maintains | Underweight |
| 09/13/2023 | 42.15% | TD Cowen | → $10 | Initiates Coverage On | → Underperform |
| 08/08/2023 | 84.79% | BMO Capital | $14 → $13 | Maintains | Market Perform |
| 06/01/2023 | 27.93% | Barclays | $10 → $9 | Maintains | Underweight |
| 05/12/2023 | 70.58% | Mizuho | $20 → $12 | Maintains | Neutral |
| 04/14/2023 | 127.43% | BMO Capital | → $16 | Reinstates | → Market Perform |
| 02/27/2023 | 42.15% | Credit Suisse | → $10 | Reiterates | → Underperform |
| 02/24/2023 | 155.86% | Bernstein | $10 → $18 | Maintains | Market Perform |
| 02/24/2023 | 184.29% | Mizuho | $11 → $20 | Maintains | Neutral |
| 12/09/2022 | — | Argus Research | Downgrades | Hold → Sell | |
| 11/28/2022 | 42.15% | Barclays | $13 → $10 | Downgrades | Equal-Weight → Underweight |
| 11/23/2022 | -28.93% | Goldman Sachs | $14 → $5 | Maintains | Sell |
| 11/10/2022 | 99% | BMO Capital | $20 → $14 | Maintains | Market Perform |
| 11/10/2022 | 56.36% | Mizuho | $27 → $11 | Maintains | Neutral |
| 10/17/2022 | 99% | Canaccord Genuity | $15 → $14 | Maintains | Hold |
| 10/17/2022 | 84.79% | Barclays | $30 → $13 | Maintains | Equal-Weight |
| 10/17/2022 | -14.71% | Piper Sandler | $8 → $6 | Maintains | Underweight |
| 10/12/2022 | 113.22% | Canaccord Genuity | $22 → $15 | Maintains | Hold |
| 09/21/2022 | 13.72% | Piper Sandler | $9 → $8 | Maintains | Underweight |
| 08/23/2022 | 27.93% | Piper Sandler | $12 → $9 | Maintains | Underweight |
| 08/08/2022 | 283.8% | Mizuho | $21 → $27 | Maintains | Neutral |
| 08/08/2022 | 326.44% | Barclays | $25 → $30 | Maintains | Equal-Weight |
| 08/05/2022 | 326.44% | UBS | $20 → $30 | Maintains | Neutral |
| 08/05/2022 | 42.15% | B of A Securities | $20 → $10 | Maintains | Underperform |
| 05/13/2022 | 184.29% | Credit Suisse | $40 → $20 | Maintains | Underperform |
| 05/12/2022 | 269.58% | Cowen & Co. | $42 → $26 | Maintains | Market Perform |
| 05/12/2022 | 326.44% | BMO Capital | $60 → $30 | Maintains | Market Perform |
| 05/12/2022 | 198.51% | Mizuho | $35 → $21 | Maintains | Neutral |
| 05/12/2022 | 99% | Goldman Sachs | $40 → $14 | Maintains | Sell |
| 05/12/2022 | 70.58% | Piper Sandler | $29 → $12 | Maintains | Underweight |
| 05/12/2022 | 255.37% | Barclays | $80 → $25 | Downgrades | Overweight → Equal-Weight |
| 05/03/2022 | 397.51% | Mizuho | $45 → $35 | Maintains | Neutral |
| 03/30/2022 | 582.3% | UBS | → $48 | Initiates Coverage On | → Neutral |
| 03/28/2022 | 312.22% | Piper Sandler | $50 → $29 | Downgrades | Neutral → Underweight |
| 03/07/2022 | 468.59% | Goldman Sachs | $47 → $40 | Maintains | Sell |
| 02/28/2022 | 752.88% | BMO Capital | $68 → $60 | Maintains | Market Perform |
| 02/25/2022 | 610.73% | Canaccord Genuity | $80 → $50 | Maintains | Hold |
| 02/25/2022 | 354.87% | JP Morgan | $54 → $32 | Maintains | Underweight |
| 02/25/2022 | 610.73% | Piper Sandler | $64 → $50 | Maintains | Neutral |
| 02/25/2022 | 539.66% | Mizuho | $59 → $45 | Maintains | Neutral |
| 02/02/2022 | 866.6% | BMO Capital | → $68 | Initiates Coverage On | → Market Perform |
| 01/31/2022 | 1037.17% | Barclays | $70 → $80 | Upgrades | Underweight → Overweight |
| 01/27/2022 | 738.66% | Mizuho | → $59 | Initiates Coverage On | → Neutral |
| 01/21/2022 | — | HSBC | Downgrades | Reduce → Hold | |
| 12/14/2021 | 809.74% | Piper Sandler | $61 → $64 | Upgrades | Underweight → Neutral |
| 11/30/2021 | 781.31% | HSBC | → $62 | Initiates Coverage On | → Reduce |
| 11/11/2021 | 923.45% | Piper Sandler | $95 → $72 | Maintains | Underweight |
| 11/11/2021 | 752.88% | Credit Suisse | $75 → $60 | Maintains | Underperform |
| 11/11/2021 | 1321.46% | Bernstein | → $100 | Downgrades | Outperform → Market Perform |
| 10/27/2021 | 1321.46% | Canaccord Genuity | $125 → $100 | Maintains | Hold |
| 10/26/2021 | 966.1% | Credit Suisse | $123 → $75 | Downgrades | Neutral → Underperform |
| 10/25/2021 | 1634.19% | Citigroup | $165 → $122 | Maintains | Buy |
| 10/25/2021 | 1037.17% | Barclays | $90 → $80 | Maintains | Underweight |
| 09/16/2021 | 1250.39% | Piper Sandler | $120 → $95 | Downgrades | Neutral → Underweight |
| 09/10/2021 | 1662.62% | Cowen & Co. | → $124 | Initiates Coverage On | → Market Perform |
| 08/25/2021 | — | Argus Research | Downgrades | Buy → Hold | |
| 05/28/2021 | 1648.4% | Credit Suisse | $120 → $123 | Maintains | Neutral |
| 05/24/2021 | 1747.9% | Bernstein | → $130 | Upgrades | Underperform → Outperform |
| 05/11/2021 | 1179.32% | Barclays | $100 → $90 | Maintains | Underweight |
| 05/11/2021 | 2245.42% | Citigroup | $184 → $165 | Maintains | Buy |
| 05/10/2021 | 1676.83% | Canaccord Genuity | $155 → $125 | Maintains | Hold |
| 05/10/2021 | 1250.39% | DA Davidson | $145 → $95 | Maintains | Underperform |
| 05/07/2021 | 1307.25% | Goldman Sachs | $112 → $99 | Maintains | Sell |
| 03/19/2021 | 2600.78% | Stephens & Co. | → $190 | Initiates Coverage On | → Overweight |
| 03/16/2021 | 1193.53% | JP Morgan | $94 → $91 | Maintains | Underweight |
| 03/02/2021 | — | Citigroup | Upgrades | Neutral → Buy | |
| 03/01/2021 | 1961.12% | DA Davidson | $133 → $145 | Maintains | Underperform |
| 02/26/2021 | 1492.04% | Goldman Sachs | $105 → $112 | Maintains | Sell |
| 02/26/2021 | 2103.27% | Canaccord Genuity | $170 → $155 | Maintains | Hold |
| 02/03/2021 | 1818.98% | DA Davidson | $133 → $135 | Downgrades | Neutral → Underperform |
| 01/27/2021 | 2316.49% | Canaccord Genuity | $125 → $170 | Maintains | Hold |
| 01/22/2021 | — | Longbow Research | Initiates Coverage On | → Neutral | |
| 01/20/2021 | — | BTIG | Downgrades | Buy → Neutral | |
| 01/06/2021 | 1676.83% | Piper Sandler | $144 → $125 | Downgrades | Overweight → Neutral |
| 11/10/2020 | 1037.17% | CFRA | $100 → $80 | Maintains | Sell |
| 11/10/2020 | 1676.83% | Canaccord Genuity | $140 → $125 | Maintains | Hold |
| 11/10/2020 | 1946.91% | Piper Sandler | → $144 | Upgrades | Neutral → Overweight |
| 11/10/2020 | 1420.97% | UBS | → $107 | Upgrades | Sell → Neutral |
| 10/13/2020 | 1833.19% | Bernstein | → $136 | Downgrades | Market Perform → Underperform |
| 10/06/2020 | 2430.21% | Piper Sandler | $130 → $178 | Maintains | Neutral |
| 09/18/2020 | 1634.19% | JP Morgan | → $122 | Downgrades | Neutral → Underweight |
| 09/03/2020 | 2174.34% | Baird | → $160 | Initiates Coverage On | → Outperform |
| 08/31/2020 | 1904.26% | Citigroup | $123 → $141 | Upgrades | Sell → Neutral |
| 08/05/2020 | 1463.61% | UBS | $105 → $110 | Maintains | Sell |
| 07/28/2020 | 1890.05% | Canaccord Genuity | → $140 | Initiates Coverage On | → Hold |
| 07/10/2020 | 1648.4% | Citigroup | → $123 | Initiates Coverage On | → Sell |
| 07/09/2020 | 1790.55% | Bernstein | $118 → $133 | Maintains | Market Perform |
| 07/09/2020 | 1392.54% | UBS | $75 → $105 | Maintains | Sell |
| 06/29/2020 | 1534.68% | Barclays | → $115 | Downgrades | Overweight → Underweight |
| 06/17/2020 | 1918.48% | Credit Suisse | $90 → $142 | Maintains | Neutral |
| 05/19/2020 | 2359.13% | BTIG | → $173 | Initiates Coverage On | → Buy |
| 05/06/2020 | 1250.39% | JP Morgan | $77 → $95 | Maintains | Neutral |
| 05/06/2020 | 1079.82% | DA Davidson | $62 → $83 | Maintains | Neutral |
| 05/06/2020 | 966.1% | UBS | $73 → $75 | Maintains | Sell |
| 05/06/2020 | 866.6% | B of A Securities | $58 → $68 | Reiterates | → Underperform |
| 05/01/2020 | 923.45% | Wells Fargo | → $72 | Downgrades | Equal-Weight → Underweight |
| 04/27/2020 | 937.67% | UBS | $90 → $73 | Downgrades | Neutral → Sell |
| 04/08/2020 | 1179.32% | Credit Suisse | $118 → $90 | Maintains | Neutral |
| 04/02/2020 | 923.45% | Piper Sandler | $115 → $72 | Maintains | Neutral |
| 03/31/2020 | 1321.46% | Barclays | $130 → $100 | Maintains | Overweight |
| 03/26/2020 | 454.37% | Goldman Sachs | $129 → $39 | Downgrades | Neutral → Sell |
| 03/19/2020 | — | B of A Securities | Downgrades | Neutral → Underperform | |
| 03/11/2020 | 1435.18% | JP Morgan | $134 → $108 | Maintains | Neutral |
| 03/04/2020 | 1747.9% | Argus Research | → $130 | Initiates Coverage On | → Buy |
| 02/28/2020 | 1420.97% | Jefferies | $130 → $107 | Maintains | Hold |
| 02/28/2020 | 1179.32% | UBS | $85 → $90 | Maintains | Neutral |
| 02/12/2020 | 1534.68% | Piper Sandler | → $115 | Initiates Coverage On | → Neutral |
| 01/28/2020 | 1804.76% | JP Morgan | $138 → $134 | Downgrades | Overweight → Neutral |
| 01/17/2020 | 1676.83% | Credit Suisse | $115 → $125 | Maintains | Neutral |
| 01/15/2020 | 1406.75% | Bernstein | → $106 | Downgrades | Outperform → Market Perform |
| 01/08/2020 | 1406.75% | Bernstein | → $106 | Maintains | Outperform |
| 12/03/2019 | — | Oppenheimer | Initiates Coverage On | → Perform | |
| 11/14/2019 | 1321.46% | Berenberg | → $100 | Initiates Coverage On | → Buy |
| 11/08/2019 | 1108.24% | UBS | → $85 | Initiates Coverage On | → Neutral |
| 11/05/2019 | 1406.75% | Bernstein | → $106 | Upgrades | Market Perform → Outperform |
| 10/29/2019 | 1094.03% | DA Davidson | $130 → $84 | Maintains | Underperform |
| 10/29/2019 | 1321.46% | Wells Fargo | $125 → $100 | Maintains | Market Perform |
| 10/29/2019 | 1534.68% | Credit Suisse | $135 → $115 | Maintains | Neutral |
| 10/14/2019 | 1676.83% | Wells Fargo | → $125 | Initiates Coverage On | → Market Perform |
| 09/23/2019 | — | Exane BNP Paribas | Initiates Coverage On | → Underperform | |
| 09/19/2019 | 2529.71% | Barclays | → $185 | Initiates Coverage On | → Overweight |
| 09/06/2019 | 1747.9% | DA Davidson | → $130 | Initiates Coverage On | → Underperform |
| 08/20/2019 | 2586.57% | JP Morgan | $188 → $189 | Upgrades | Neutral → Overweight |
| 08/02/2019 | 2487.06% | B of A Securities | $170 → $182 | Reiterates | → Neutral |
| 06/12/2019 | 1648.4% | Bernstein | → $123 | Downgrades | Outperform → Market Perform |
| 06/11/2019 | 1619.97% | JP Morgan | $120 → $121 | Downgrades | Overweight → Neutral |
| 06/07/2019 | 1676.83% | Credit Suisse | $70 → $125 | Maintains | Neutral |
| 06/07/2019 | 1605.76% | JP Morgan | $97 → $120 | Maintains | Overweight |
| 05/28/2019 | 1108.24% | B of A Securities | → $85 | Initiates Coverage On | → Neutral |
| 05/28/2019 | 1278.82% | JP Morgan | → $97 | Initiates Coverage On | → Overweight |
| 05/28/2019 | — | William Blair | Initiates Coverage On | → Market Perform | |
| 05/28/2019 | 895.02% | Credit Suisse | → $70 | Initiates Coverage On | → Neutral |
| 05/28/2019 | 1278.82% | JP Morgan | → $97 | Initiates Coverage On | → Overweight |
| 05/28/2019 | 1108.24% | Jefferies | → $85 | Initiates Coverage On | → Hold |
| 05/28/2019 | 852.38% | Goldman Sachs | → $67 | Initiates Coverage On | → Neutral |
| 05/20/2019 | — | Consumer Edge Research | Initiates Coverage On | → Equal-Weight | |
| 05/07/2019 | — | Bernstein | Initiates Coverage On | → Outperform |
What is the target price for Beyond Meat (BYND)?
The latest price target for Beyond Meat (NASDAQ: BYND) was reported by BMO Capital on November 9, 2023. The analyst firm set a price target for $7.00 expecting BYND to fall to within 12 months (a possible -0.50% downside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Beyond Meat (BYND)?
The latest analyst rating for Beyond Meat (NASDAQ: BYND) was provided by BMO Capital, and Beyond Meat maintained their market perform rating.
When is the next analyst rating going to be posted or updated for Beyond Meat (BYND)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Beyond Meat, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Beyond Meat was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating Beyond Meat (BYND) correct?
While ratings are subjective and will change, the latest Beyond Meat (BYND) rating was a maintained with a price target of $13.00 to $7.00. The current price Beyond Meat (BYND) is trading at is $7.04, which is out of the analyst's predicted range.